文献速递外周动脉疾病

融合影像在股浅动脉腔内血运重建中的疗效

Efficacy of Fusion Imaging in Endovascular Revascularization of the Superficial Femoral Artery.
PubMed 文献 · Ann Vasc Surg · 2021-10-14

该回顾性研究纳入2016年2月至2020年7月因外周动脉疾病(PAD)接受股浅动脉(SFA)腔内血运重建(ER)的51例患者,比较使用融合影像组(n=26)与未使用组(n=25)。结果显示融合影像组的造影剂剂量、透视时间、辐射剂量和手术时间均显著低于对照组。

要点

  • 融合影像可显著降低SFA腔内血运重建的碘造影剂剂量(56.1±23.7 vs 87.9±44.9 mL,P=0.003)。
  • 融合影像显著缩短透视时间(21.2±11.1 vs 44.9±31.4 min,P=0.001)并降低辐射剂量(29.9±8.9 vs 122.2±223.1 mGy,P=0.04)。
  • 融合影像组的平均手术时间显著更短(88.3±32.1 vs 126.1±66.8 min,P=0.013)。

核心结论

  • 在SFA腔内血运重建中使用融合影像技术可显著减少造影剂剂量、透视时间、辐射剂量和手术时间。

研究设计与样本

  • 回顾性研究,纳入2016年2月至2020年7月接受SFA腔内血运重建的PAD患者,融合影像组26例,对照组25例。

主要发现

  • 融合影像组碘造影剂剂量显著低于对照组(56.1±23.7 vs 87.9±44.9 mL;P=0.003)。
  • 融合影像组透视时间显著短于对照组(21.2±11.1 vs 44.9±31.4 min;P=0.001)。
  • 融合影像组辐射剂量显著低于对照组(29.9±8.9 vs 122.2±223.1 mGy;P=0.04)。
  • 融合影像组手术时间显著短于对照组(88.3±32.1 vs 126.1±66.8 min;P=0.013)。

临床怎么用

  • 对SFA病变行腔内血运重建时可考虑使用融合影像,以减少造影剂用量、辐射暴露和手术时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The demand for endovascular revascularization (ER) to treat peripheral artery disease (PAD) has steadily increased. However, ER comes at the cost of increased contrast and radiation exposure, particularly in more complex cases. Fusion imaging is a new technology that may address these issues. The purpose of this study was to evaluate the efficacy of fusion imaging in ER of the superficial femoral artery (SFA). METHODS: Patients with PAD undergoing ER of the SFA from February 2016 to July 2020 were retrospectively evaluated. A group of patients treated using fusion imaging was compared with a control group treated without fusion imaging. The primary end points were the contrast dose, fluoroscopy time, radiation dose, and operative time. RESULTS: A total of 51 patients (fusion group, n = 26; control group, n = 25) underwent ER during the study period. Significantly lower iodinated contrast doses were observed in the fusion than in the control group (56.1 ± 23.7 vs. 87.9 ± 44.9 mL; P = 0.003), as well as significantly shorter fluoroscopy times (21.2 ± 11.1 vs. 44.9 ± 31.4 min; P = 0.001), lower radiation exposure (29.9 ± 8.9 vs. 122.2 ± 223.1 mGy; P = 0.04), and shorter operative times (88.3 ± 32.1 vs. 126.1 ± 66.8 min; P = 0.013). CONCLUSIONS: The use of fusion imaging technology during ER of the SFA can significantly reduce the contrast dose, fluoroscopy time, radiation dose, and operative time.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Haga M, Fujimura K, Shindo S, et al. Efficacy of Fusion Imaging in Endovascular Revascularization of the Superficial Femoral Artery. Ann Vasc Surg. 2021. PMID: 34656727. doi:10.1016/j.avsg.2021.08.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。